| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Frans RJ Verhey | Q68596187 |
| Lyzel S. Elias‐Sonnenschein | Q112130821 | ||
| Wolfgang Viechtbauer | Q39393014 | ||
| P2093 | author name string | Pieter Jelle Visser | |
| Inez H G B Ramakers | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 1149-1156 | |
| P577 | publication date | 2011-04-14 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis. | |
| P478 | volume | 82 |
| Q64988752 | A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information. |
| Q24201260 | APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting |
| Q24201271 | APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting |
| Q24201265 | APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting |
| Q34096072 | APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease. |
| Q34139700 | APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment |
| Q38784011 | APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review |
| Q37154399 | APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death |
| Q92691831 | APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment |
| Q57418473 | Age dependency of risk factors for cognitive decline |
| Q38088622 | Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease |
| Q39217840 | Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid |
| Q38605663 | Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis |
| Q28282855 | Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy |
| Q36782197 | Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults. |
| Q35118492 | Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies |
| Q38686493 | Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study |
| Q48873908 | Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort |
| Q28730043 | Assessing and managing risk when sharing aggregate genetic variant data |
| Q36369026 | Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEε4 Allele |
| Q50104994 | Big Data and Dementia: Charting the Route Ahead for Research, Ethics, and Policy |
| Q47132754 | Changes of Functional and Directed Resting-State Connectivity Are Associated with Neuronal Oscillations, ApoE Genotype and Amyloid Deposition in Mild Cognitive Impairment |
| Q45480945 | Endothelial dysfunction associated with mild cognitive impairment in elderly population. |
| Q58693792 | Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes |
| Q97684707 | Factors influencing recovery from mild traumatic brain injury |
| Q88978887 | Genetic Risk for Age-Related Cognitive Impairment Does Not Predict Cognitive Performance in Middle Age |
| Q44261310 | Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease |
| Q39512782 | Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicine |
| Q38847374 | Genome research in pre-dementia stages of Alzheimer's disease |
| Q33629452 | Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment |
| Q34670399 | Heritability and molecular-genetic basis of resting EEG activity: a genome-wide association study |
| Q64120505 | How pattern information analyses of semantic brain activity elicited in language comprehension could contribute to the early identification of Alzheimer's Disease |
| Q33692793 | How well do MCI criteria predict progression to severe cognitive impairment and dementia? |
| Q92509524 | Impacts of apolipoprotein E disclosure on healthy Asian older adults: a cohort study |
| Q37412664 | Interaction between C-reactive protein and cognitive functions according to APOE gene polymorphism in post-menopausal women |
| Q64936623 | Lifespan Intellectual Factors, Genetic Susceptibility, and Cognitive Phenotypes in Aging: Implications for Interventions. |
| Q37261529 | Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model. |
| Q51481172 | Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease. |
| Q41549578 | Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism. |
| Q93154036 | Predicting Early Mild Cognitive Impairment With Free Recall: The Primacy of Primacy |
| Q64258302 | Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics |
| Q46083684 | Prediction Model of Conversion to Dementia Risk in Subjects with Amnestic Mild Cognitive Impairment: A Longitudinal, Multi-Center Clinic-Based Study. |
| Q91729162 | Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid |
| Q35895780 | Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity |
| Q89699846 | Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases |
| Q50535439 | Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. |
| Q38037159 | Relationship between genetic risk factors and markers for Alzheimer's disease pathology |
| Q38498447 | Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies |
| Q38149355 | Risk factors for the progression of mild cognitive impairment to dementia |
| Q34653876 | Screening for disease, psychological testing, and psychotherapy Looking behind the mirror |
| Q103001592 | Selecting the most important self-assessed features for predicting conversion to mild cognitive impairment with random forest and permutation-based methods |
| Q36216485 | Serum albumin to globulin ratio is related to cognitive decline via reflection of homeostasis: a nested case-control study. |
| Q34717480 | Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E. |
| Q50564711 | The Association of Apolipoprotein E Gene Polymorphism With Cognitive Performance in Nondemented Polish Adults Aged 55 to 75. |
| Q64121665 | The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk |
| Q24289484 | The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data |
| Q27693353 | The diagnosis and management of mild cognitive impairment: a clinical review |
| Q64108331 | The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study |
| Q38001577 | The prognostic value of amyloid imaging. |
| Q94398269 | ‐ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting |
| Q94397816 | ‐ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting |
| Q94398626 | ‐ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting |
Search more.